A Common Polymorphism in the 5′-Untranslated Region of the VEGF Gene Is Associated With Diabetic Retinopathy in Type 2 Diabetes
- 1 May 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (5), 1635-1639
- https://doi.org/10.2337/diabetes.51.5.1635
Abstract
Vascular endothelial growth factor (VEGF), a major mediator of vascular permeability and angiogenesis, may play a pivotal role in mediating the development and progression of diabetic retinopathy. In the present study, we examined the genetic variations of the VEGF gene to assess its possible relation to diabetic retinopathy in type 2 diabetic patients. Among seven common polymorphisms in the promoter region, 5′-untranslated region (UTR) and 3′UTR of the VEGF gene, genotype distribution of the C(−634)G polymorphism differed significantly (P = 0.011) between patients with (n = 150) and without (n = 118) retinopathy, and the C allele was significantly increased in patients with retinopathy compared with those without retinopathy (P = 0.0037). The odds ratio (OR) for the CC genotype of C(−634)G to the GG genotype was 3.20 (95% CI 1.45–7.05, P = 0.0046). The −634C allele was significantly increased in patients with nonproliferative diabetic retinopathy (non-PDR) (P = 0.0026) and was insignificantly increased in patients with proliferative diabetic retinopathy (PDR) (P = 0.081) compared with patients without retinopathy, although frequencies of the allele did not differ significantly between the non-PDR and PDR groups. Logistic regression analysis revealed that the C(−634)G polymorphism was strongly associated with an increased risk of retinopathy (P = 0.0018). Furthermore, VEGF serum levels were significantly higher in healthy subjects with the CC genotype of the C(−634)G polymorphism than in those with the other genotypes. These data suggest that the C(−634)G polymorphism in the 5′UTR of the VEGF gene is a novel genetic risk factor for diabetic retinopathy.Keywords
This publication has 24 references indexed in Scilit:
- A Common 936 C/T Mutation in the Gene for Vascular Endothelial Growth Factor Is Associated with Vascular Endothelial Growth Factor Plasma LevelsJournal of Vascular Research, 2000
- IDENTIFICATION OF POLYMORPHISMS WITHIN THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) GENE: CORRELATION WITH VARIATION IN VEGF PROTEIN PRODUCTIONCytokine, 2000
- A Variant of Paraoxonase (PON1) Gene Is Associated with Diabetic Retinopathy in IDDMJournal of Clinical Endocrinology & Metabolism, 1998
- β3-Adrenoreceptor Gene Polymorphism: A Newly Identified Risk Factor for Proliferative Retinopathy in NIDDM PatientsDiabetes, 1997
- The Biology of Vascular Endothelial Growth FactorEndocrine Reviews, 1997
- Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult PrimateOphthalmology, 1996
- HLA-DQB1 * 0201/0302 is associated with severe retinopathy in patients with IDDMDiabetologia, 1996
- Vascular Endothelial Growth Factor -- Its Role in Retinal Vascular ProliferationThe New England Journal of Medicine, 1994
- Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal DisordersThe New England Journal of Medicine, 1994
- The HLA Polymorphism and Susceptibility to DiseaseVox Sanguinis, 1976